Polarized macrophage functions are affected differentially after CSF-1R inhibition with PLX5622

被引:0
|
作者
Barilo, Julia [1 ]
Bouzeineddine, Nasry Zane [1 ]
Philippi, Alecco [1 ]
Basta, Sam [1 ]
机构
[1] Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON K7L 3N6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
M-CSF; Cytokines; Polarization; CSF-1R; COLONY-STIMULATING FACTOR; TUMOR-ASSOCIATED MACROPHAGES; MONONUCLEAR PHAGOCYTES; EXPRESSION; DERIVATION; EFFICACY; IMPROVES; CULTURE; CROSS;
D O I
10.1016/j.ejphar.2024.177059
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PLX5622 is a colony stimulating factor 1 receptor (CSF-1R) inhibitor that is known to deplete microglial cells in vivo. Recently its effects on macrophages (M phi) were also observed in vivo. Therefore, we performed this study to assess its in vitro effects on the differentiation and functions of polarized M phi derived from different tissues. Our findings show that addition of PLX5622 early on after ex vivo isolation hinders M phi differentiation and survival. However, its addition post M phi differentiation did not significantly affect the viability. Furthermore, PLX5622 affects certain functions and degree of polarization of IL-4 (M2a) M phi but not polarization of M1-like M phi. Our study provides novel aspects on the application of PLX5622 to study M phi functions in vitro, where polarization is affected by CSF-1R signalling and provides distinctive evidence to its ability to affect certain populations of M phi during in vitro differentiation and maturation.
引用
收藏
页数:11
相关论文
共 19 条
  • [1] CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice
    Bosch, Angela J. T.
    Keller, Lena
    Steiger, Laura
    Rohm, Theresa V.
    Wiedemann, Sophia J.
    Low, Andy J. Y.
    Stawiski, Marc
    Rachid, Leila
    Roux, Julien
    Konrad, Daniel
    Wueest, Stephan
    Tugues, Sonia
    Greter, Melanie
    Boni-Schnetzler, Marianne
    Meier, Daniel T.
    Cavelti-Weder, Claudia
    DIABETOLOGIA, 2023, 66 (12) : 2292 - 2306
  • [2] Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy
    Shang, Qingchao
    Zhang, Pei
    Lei, Xiao
    Du, Lehui
    Qu, Baolin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] CSF-1R inhibition alters macrophage polarization and blocks glioma progression
    Pyonteck, Stephanie M.
    Akkari, Leila
    Schuhmacher, Alberto J.
    Bowman, Robert L.
    Sevenich, Lisa
    Quail, Daniela F.
    Olson, Oakley C.
    Quick, Marsha L.
    Huse, Jason T.
    Teijeiro, Virginia
    Setty, Manu
    Leslie, Christina S.
    Oei, Yoko
    Pedraza, Alicia
    Zhang, Jianan
    Brennan, Cameron W.
    Sutton, James C.
    Holland, Eric C.
    Daniel, Dylan
    Joyce, Johanna A.
    NATURE MEDICINE, 2013, 19 (10) : 1264 - +
  • [4] Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
    Akkari, Leila
    Bowman, Robert L.
    Tessier, Jeremy
    Klemm, Florian
    Handgraaf, Shanna M.
    de Groot, Marnix
    Quail, Daniela F.
    Tillard, Lucie
    Gadiot, Jules
    Huse, Jason T.
    Brandsma, Dieta
    Westerga, Johan
    Watts, Colin
    Joyce, Johanna A.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (552)
  • [5] Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors
    Wesolowski, Robert
    Sharma, Neelesh
    Reebel, Laura
    Rodal, Mary Beth
    Peck, Alexandra
    West, Brian L.
    Marimuthu, Adhirai
    Severson, Paul
    Karlin, David A.
    Dowlati, Afshin
    Le, Mai H.
    Coussens, Lisa M.
    Rugo, Hope S.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [6] The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
    Swierczak, Agnieszka
    Cook, Andrew D.
    Lenzo, Jason C.
    Restall, Christina M.
    Doherty, Judy P.
    Anderson, Robin L.
    Hamilton, John A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (08) : 765 - 776
  • [7] CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression
    Li, Kun
    Xu, Wenfu
    Lu, Ke
    Wen, Yuxi
    Xin, Tianqing
    Shen, Yaqing
    Lv, Xueyan
    Hu, Shimin
    Jin, Runming
    Wu, Xiaoyan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (22) : 13115 - 13128
  • [8] Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction
    Leblond, Anne-Laure
    Klinkert, Kerstin
    Martin, Kenneth
    Turner, Elizebeth C.
    Kumar, Arun H.
    Browne, Tara
    Caplice, Noel M.
    PLOS ONE, 2015, 10 (09):
  • [9] Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells
    Akhabue K. Okojie
    Joseph O. Uweru
    Morgan A. Coburn
    Sihan Li
    Vivian D. Cao-Dao
    Ukpong B. Eyo
    Journal of Neuroinflammation, 20
  • [10] Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells
    Okojie, Akhabue K.
    Uweru, Joseph O.
    Coburn, Morgan A.
    Li, Sihan
    Cao-Dao, Vivian D.
    Eyo, Ukpong B.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)